Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Chiesa

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
Therapeutic Drug Monitoring|September 14, 2012
Predictive performance of a busulfan pharmacokinetic model in children and young adultsImke H Bartelink, Charlotte van Kesteren, Jaap J Boelens, et al.
British Journal of Haematology|September 15, 2009
Absence of VOD in paediatric thalassaemic HSCT recipients using defibrotide prophylaxis and intravenous BusulphanBarbara Cappelli, Robert Chiesa, Costanza Evangelio, et al.
The New England Journal of Medicine|June 14, 2023
Base-Edited CAR7 T Cells for Relapsed T-Cell Acute Lymphoblastic LeukemiaRobert Chiesa, Christos Georgiadis, Farhatullah Syed, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 8, 2009
Unpredictability of intravenous busulfan pharmacokinetics in children undergoing hematopoietic stem cell transplantation for advanced beta thalassemia: limited toxicity with a dose-adjustment policyRobert Chiesa, Barbara Cappelli, Roberto Crocchiolo, et al.
Frontiers in Immunology|November 21, 2018
Clinical T Cell Receptor Repertoire Deep Sequencing and Analysis: An Application to Monitor Immune Reconstitution Following Cord Blood TransplantationAthina Soragia Gkazi, Ben K Margetts, Teresa Attenborough, et al.
British Journal of Haematology|July 9, 2025
Defining a CMV viral load threshold for pre-emptive therapy in paediatric haematopoietic stem cell transplant recipientsAmedine Duret, Oscar Charles, Ben K Margetts, et al.
British Journal of Haematology|April 10, 2026
Treosulfan-fludarabine conditioning in infants with severe combined immunodeficiencies: Extended study of the UK paediatric treosulfan studySu Han Lum, Sinéad Greener, Irum Latif Memon, et al.
Journal of Human Immunity|May 22, 2026
Beyond survival: Multisystem long-term outcomes following HSCT in chronic granulomatous diseaseValentina Guarnieri, Jesmeen Maimaris, Sohilla Lotfy, et al.
British Journal of Haematology|July 1, 2026
Outcomes of invasive fungal infections in 358 children undergoing allogeneic haematopoietic stem cell transplantation: A prospective UK studyGiorgio Ottaviano, Emanuele Lanino, Zohreh Nademi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 21, 2017
Treosulfan and Fludarabine Conditioning for Hematopoietic Stem Cell Transplantation in Children with Primary Immunodeficiency: UK ExperienceMary A Slatter, Kanchan Rao, Intan Juliana Abd Hamid, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Therapeutic Drug Monitoring|September 14, 2012
Predictive performance of a busulfan pharmacokinetic model in children and young adultsImke H Bartelink, Charlotte van Kesteren, Jaap J Boelens, et al.
British Journal of Haematology|September 15, 2009
Absence of VOD in paediatric thalassaemic HSCT recipients using defibrotide prophylaxis and intravenous BusulphanBarbara Cappelli, Robert Chiesa, Costanza Evangelio, et al.
The New England Journal of Medicine|June 14, 2023
Base-Edited CAR7 T Cells for Relapsed T-Cell Acute Lymphoblastic LeukemiaRobert Chiesa, Christos Georgiadis, Farhatullah Syed, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 8, 2009
Unpredictability of intravenous busulfan pharmacokinetics in children undergoing hematopoietic stem cell transplantation for advanced beta thalassemia: limited toxicity with a dose-adjustment policyRobert Chiesa, Barbara Cappelli, Roberto Crocchiolo, et al.
Frontiers in Immunology|November 21, 2018
Clinical T Cell Receptor Repertoire Deep Sequencing and Analysis: An Application to Monitor Immune Reconstitution Following Cord Blood TransplantationAthina Soragia Gkazi, Ben K Margetts, Teresa Attenborough, et al.
British Journal of Haematology|July 9, 2025
Defining a CMV viral load threshold for pre-emptive therapy in paediatric haematopoietic stem cell transplant recipientsAmedine Duret, Oscar Charles, Ben K Margetts, et al.
British Journal of Haematology|April 10, 2026
Treosulfan-fludarabine conditioning in infants with severe combined immunodeficiencies: Extended study of the UK paediatric treosulfan studySu Han Lum, Sinéad Greener, Irum Latif Memon, et al.
Journal of Human Immunity|May 22, 2026
Beyond survival: Multisystem long-term outcomes following HSCT in chronic granulomatous diseaseValentina Guarnieri, Jesmeen Maimaris, Sohilla Lotfy, et al.
British Journal of Haematology|July 1, 2026
Outcomes of invasive fungal infections in 358 children undergoing allogeneic haematopoietic stem cell transplantation: A prospective UK studyGiorgio Ottaviano, Emanuele Lanino, Zohreh Nademi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 21, 2017
Treosulfan and Fludarabine Conditioning for Hematopoietic Stem Cell Transplantation in Children with Primary Immunodeficiency: UK ExperienceMary A Slatter, Kanchan Rao, Intan Juliana Abd Hamid, et al.
Pageof 7